Quick Answer Box
- What is this case? Federal litigation against Procter & Gamble alleging that Always-brand feminine pads contain PFAS chemicals linked to cancer, endocrine disruption, and reproductive harm, which P&G failed to disclose to consumers.
- Who qualifies? Women who purchased or used Always pads within applicable state statute of limitations periods, or who developed a PFAS-linked health condition following prolonged use, may have standing to bring consumer fraud or personal injury claims.
- What is it worth? Consumer class claims may yield modest per-person recoveries of $50 to $500. Personal injury cases tied to documented health conditions carry significantly higher potential value, with individual claims estimated between $50,000 and $500,000 depending on diagnosis severity and duration of use.
Case Snapshot
| Detail | Information |
|---|---|
| Court | U.S. District Court, Northern District of Illinois |
| Case / MDL Reference | Consolidated proceedings; related MDL coordination pending as of early 2026 |
| Initial Complaint Filed | 2023 (amended complaints filed through 2025) |
| Current Status | Active litigation; class certification briefing ongoing |
| Defendant | Procter & Gamble Co. |
| Products at Issue | Always Infinity, Always Radiant, Always Discreet, Always Maxi |
| Settlement Fund | No global settlement reached as of publication; individual case resolutions reported |
| Key Chemical | PFAS, including PTFE (polytetrafluoroethylene) |
The always pads lawsuit is one of the more consequential PFAS personal care product cases in active federal litigation heading into 2026. Procter & Gamble faces allegations that its Always line of feminine hygiene pads contains per- and polyfluoroalkyl substances, chemicals with documented links to cancer, thyroid disease, and reproductive disorders. The company sold these products to tens of millions of American women without disclosing the presence of those compounds.
Independent laboratory analyses, referenced in operative complaints, detected PFAS at measurable concentrations in multiple Always product variants. That finding sits at the center of this litigation.
Two separate legal tracks are running simultaneously. One is a consumer fraud class action focused on economic harm, the premise being that women would not have paid for the product had they known about the contamination. The other involves personal injury mass tort claims from women alleging they developed PFAS-linked conditions after years of use.
Understanding which track applies to a specific claimant is the most important threshold question in 2026.
Always Pads Lawsuit 2026: What Is This Case and Where Does It Stand?
The always pads lawsuit 2026 refers to the body of consolidated civil litigation against Procter & Gamble alleging undisclosed PFAS contamination in its Always feminine pad products. This litigation is active in federal court, with the Northern District of Illinois serving as the primary venue for consolidated proceedings.
Plaintiffs filed initial complaints in 2023 following independent third-party laboratory testing. Several amended complaints followed in 2024 and 2025 as additional product testing results became available and new plaintiffs joined.
The case is significant for two structural reasons. First, it names one of the world's largest consumer goods companies as defendant. Second, it involves a product used by millions of women on a recurring, intimate basis, which courts generally treat as a factor in both liability and damages analysis.
Key facts at a glance:
- Filed initially: 2023
- Primary court: N.D. Illinois
- Products named: Always Infinity, Always Radiant, Always Discreet, Always Maxi
- Core claim: Failure to warn, consumer fraud, strict product liability
- Defendant: Procter & Gamble Co.
*Attorney Insight: Attorneys handling these claims note that the recurring, intimate-contact nature of the product distinguishes it from typical consumer goods PFAS cases, because courts tend to scrutinize the duty-to-warn analysis more carefully when exposure is both prolonged and personal.*
Procter & Gamble Always Pads Lawsuit: The Corporate Defendant and Its Legal Position
Procter & Gamble is the manufacturer and marketer of the Always brand, one of the top-selling feminine hygiene product lines in the United States. The company generates billions annually from its femcare segment.
P&G's public legal posture has been to contest the scientific basis of the claims. The company has argued that any PTFE or PFAS-adjacent compounds present in its products are within safe ranges and pose no demonstrated health risk at detected concentrations.
That defense strategy mirrors what other consumer product manufacturers have attempted in PFAS litigation. Courts have not uniformly accepted it.
| P&G Defense Argument | Plaintiff Counterargument |
|---|---|
| PFAS concentrations are within safe ranges | No federally established safe limit exists for PFAS in intimate contact products |
| PTFE is a stable, inert form of PFAS | Degradation under body heat may release reactive compounds |
| Product labeling meets FDA requirements | FDA has not specifically regulated PFAS disclosure in femcare |
| Independent testing is methodologically flawed | Multiple independent labs replicated findings across different product variants |
*Attorney Insight: Attorneys handling these claims point to the absence of any FDA-mandated PFAS disclosure standard for feminine hygiene products as both a regulatory gap and a liability amplifier for P&G.*
Always Pads PFAS Lawsuit: The Chemical at the Center of the Case
The always pads PFAS lawsuit turns on the presence of per- and polyfluoroalkyl substances in the pad materials themselves. PFAS is a category of more than 12,000 synthetic compounds, not a single chemical.
The specific compound most frequently cited in Always pads complaints is PTFE, short for polytetrafluoroethylene. PTFE is used commercially to create smooth, moisture-wicking surfaces. It is also classified under the broader PFAS umbrella by the EPA.
Independent lab testing cited in the operative complaints detected PTFE and related fluorinated compounds in the absorbent core and outer layers of multiple Always product variants. Concentrations varied by product type.
PFAS compounds most relevant to this litigation:
- PTFE (polytetrafluoroethylene): detected in pad materials; used to reduce friction and improve moisture management
- PFOA-related precursors: breakdown compounds associated with legacy PFAS manufacturing
- Short-chain PFAS: replacement compounds introduced after long-chain PFAS phase-outs, also under regulatory scrutiny
- Total organic fluorine: the broader measure used by some testing labs to capture all fluorinated compounds
*Attorney Insight: Attorneys handling these claims highlight that total organic fluorine testing often reveals PFAS levels that compound-specific tests miss, which is why plaintiffs have pushed for comprehensive fluorine analysis in discovery.*
Always Pads Class Action Lawsuit: How the Consumer Fraud Track Works
The always pads class action lawsuit is one of two legal tracks running in this litigation. The class action targets economic harm rather than physical injury.
The theory is straightforward. Plaintiffs allege that Procter & Gamble marketed Always pads as safe consumer products without disclosing the presence of PFAS. Had consumers known about the contamination, they would not have purchased the product, or would have paid substantially less for it.
This is a consumer fraud theory. It does not require proving that a plaintiff developed cancer or any other medical condition.
Class action claim structure:
| Element | What Plaintiffs Must Show |
|---|---|
| Misrepresentation or omission | P&G failed to disclose PFAS on labeling or in marketing |
| Materiality | A reasonable consumer would consider PFAS presence important to a purchase decision |
| Reliance | Plaintiffs purchased the product without knowledge of contamination |
| Damages | Economic loss equal to the price paid or the price premium attributable to the misrepresentation |
Class certification remains contested. P&G has challenged whether the class can be certified under Rule 23 given variations in product versions, purchase dates, and consumer knowledge across states.
*Attorney Insight: Attorneys handling these claims note that multi-state class certification in PFAS consumer fraud cases has succeeded in other product lines when plaintiffs can show uniform labeling across states and a common omission.*
Always Pads PFAS Chemicals Health Risks: What the Science Currently Shows
The always pads PFAS chemicals health risks are not theoretical. PFAS exposure is one of the most extensively studied environmental health topics in the United States as of 2026.
The EPA's 2024 maximum contaminant level rule for PFAS in drinking water established enforceable limits as low as 4 parts per trillion for certain compounds. That regulatory action reflects the federal government's own assessment that PFAS pose serious health risks at very low concentrations.
Health conditions linked to PFAS exposure in peer-reviewed literature:
- Kidney cancer and renal cell carcinoma
- Ovarian cancer and uterine cancer
- Thyroid disease and hormonal disruption
- Endometriosis and polycystic ovary syndrome
- Immune system suppression
- Elevated cholesterol and cardiovascular risk
- Developmental harm in fetuses during pregnancy
The pathway for feminine pad exposure is direct. Vaginal and vulvar tissue is highly absorbent. PFAS applied to pad materials comes into prolonged contact with sensitive mucous membranes during menstruation.
*Attorney Insight: Attorneys handling these claims point to the EPA's enforceable 2024 PFAS drinking water limits as a significant development, because those standards give plaintiffs' experts a regulatory benchmark to argue that no concentration of these compounds should be treated as safe in intimate contact products.*
Litigation Watch: P&G's safety-range defense faces direct pressure from the EPA's 2024 PFAS ruling, which established that these compounds cause health harm at concentrations far below levels previously considered safe by industry.
Always Pads Cancer Lawsuit: Specific Disease Claims and How They Are Categorized
The always pads cancer lawsuit refers specifically to personal injury claims where plaintiffs allege that PFAS exposure from Always pads caused or contributed to a cancer diagnosis. These claims sit on the mass tort track, not the class action track.
Cancer claims require a different evidentiary structure than consumer fraud claims. Plaintiffs must establish general causation (PFAS can cause this type of cancer in humans) and specific causation (this plaintiff's exposure to Always pads contributed to her specific diagnosis).
Cancer types currently associated with Always pads personal injury claims:
- Ovarian cancer
- Uterine/endometrial cancer
- Kidney cancer
- Bladder cancer
- Non-Hodgkin lymphoma (in cases involving high-level total PFAS exposure across multiple sources)
The value of these claims is substantially higher than consumer fraud class action recoveries. Documented cancer diagnoses with years of Always pad use as a contributing exposure factor support demands well above $100,000 in individual settlement negotiations.
*Attorney Insight: Attorneys handling these claims note that toxicology experts are critical in cancer cases, because defendants will require scientifically grounded testimony linking the specific PFAS compound detected in the product to the specific cancer type alleged.*
Always Pads Lawsuit Update 2026: Where the Litigation Stands Right Now
The always pads lawsuit update 2026 reflects a litigation that has moved substantially beyond early-stage motions and is now engaged in active discovery and class certification briefing.
Several developments define the current posture:
- Discovery disputes over P&G's internal testing records and communications about PFAS in its manufacturing process have been heavily litigated
- Expert designation deadlines on general causation are either completed or imminent in the lead cases
- Class certification on the consumer fraud track remains pending, with oral argument expected in 2026
- Individual case filings on the personal injury track continue to increase, with plaintiffs' firms reporting a growing docket of cancer and endocrine-disorder claimants
No global settlement has been announced as of this publication. The litigation is in the phase that typically precedes either settlement negotiations or trial preparation in complex product liability cases.
| Litigation Milestone | Status as of 2026 |
|---|---|
| Initial complaints filed | Completed (2023) |
| Amended complaints | Completed (2024-2025) |
| Motion to dismiss ruling | Resolved in plaintiffs' favor on core counts |
| Discovery (fact phase) | Ongoing |
| Expert designation | Underway |
| Class certification | Briefing phase |
| Trial date | Not yet set |
*Attorney Insight: Attorneys handling these claims observe that the discovery phase in PFAS product litigation is where cases are won or lost, because internal corporate documents often reveal whether P&G knew about PFAS levels before independent testing exposed them.*
Litigation Watch: The 2026 litigation posture shows discovery disputes and class certification briefing as the defining battlegrounds, with no global settlement announced and individual case filings continuing to grow.
Who Qualifies for Always Pads Lawsuit Claims?
Who qualifies for the always pads lawsuit depends entirely on which legal track is at issue. The eligibility criteria differ substantially between the consumer class action and the personal injury mass tort.
Consumer class action eligibility:
- Purchased any Always-brand pad product within the applicable state statute of limitations (typically 2 to 6 years depending on state consumer protection law)
- Used Always Infinity, Always Radiant, Always Discreet, or Always Maxi products
- Was not already compensated for the same purchase through any prior settlement
Personal injury eligibility:
- Used Always pads for a sustained period (plaintiffs' attorneys typically look for at least 1 to 3 years of regular use)
- Received a diagnosis of a PFAS-associated condition: ovarian cancer, uterine cancer, kidney cancer, endometriosis, thyroid disease, or related conditions
- Diagnosis occurred after a period of regular Always pad use
| Qualification Factor | Class Action | Personal Injury |
|---|---|---|
| Medical diagnosis required | No | Yes |
| Minimum use period | Any purchase | Typically 1 to 3+ years |
| Dollar damages required | Purchase price | Medical expenses, lost wages, pain and suffering |
| Proof of injury | Economic loss only | Physical harm with medical documentation |
| Potential recovery | $50 to $500 | $50,000 to $500,000+ |
*Attorney Insight: Attorneys handling these claims advise that any woman with a documented PFAS-linked diagnosis and a history of Always pad use should consult a personal injury attorney before joining any class action, because opting into a class action may limit individual recovery.*
Always Pads Lawsuit Settlement Amount: What Claimants May Recover
The always pads lawsuit settlement amount depends on which claim category a plaintiff falls into and how the litigation resolves. No global settlement has been finalized as of 2026.
For consumer class action claimants, historical PFAS consumer product settlements in analogous cases provide a range. Per-claimant payouts in class settlements for contaminated personal care products have typically ranged from $20 to $500, with higher amounts tied to documented purchase volume and state-specific consumer protection multipliers.
For personal injury claimants, the calculus is different.
Personal injury settlement value factors:
- Severity and stage of cancer diagnosis
- Duration and frequency of Always pad use
- Age at diagnosis
- Cost of medical treatment
- Income loss and future earning capacity
- Strength of causation evidence in the specific case
- Jurisdiction and applicable damages caps
Estimated personal injury value ranges:
| Diagnosis Category | Estimated Settlement Range |
|---|---|
| Early-stage cancer, strong use history | $50,000 to $150,000 |
| Advanced cancer, documented multi-year use | $150,000 to $350,000 |
| Severe/terminal cancer, compelling causation evidence | $350,000 to $500,000+ |
| Endocrine disorder without cancer | $20,000 to $75,000 |
| Endometriosis, reproductive harm | $25,000 to $100,000 |
*Attorney Insight: Attorneys handling these claims note that early case resolutions in mass torts often yield lower per-claimant amounts than cases resolved closer to trial, because litigation risk discounts diminish as causation evidence strengthens.*
Always Pads Lawsuit Compensation: Beyond Settlement Dollars
Always pads lawsuit compensation encompasses more than a single settlement payment. Claimants in both the class action and personal injury tracks may recover distinct categories of damages.
The full picture of recoverable damages varies by state law and claim type.
Categories of compensable damages in Always pads claims:
Economic damages:
- Medical expenses (past and future)
- Cost of diagnostic testing
- Lost wages and income
- Reduced earning capacity
- Cost of fertility treatments where reproductive harm is alleged
Non-economic damages:
- Pain and suffering
- Emotional distress
- Loss of enjoyment of life
- Loss of consortium (spouse/partner claims in applicable states)
Punitive damages:
- Available in states that permit punitive damages in product liability cases where corporate misconduct is demonstrated
- Punitive claims require evidence that P&G knew of PFAS presence and concealed it from consumers
States with strong consumer protection statutes, including California, New Jersey, and Illinois, provide multiplier provisions that can significantly increase base compensation in consumer fraud cases.
*Attorney Insight: Attorneys handling these claims point to punitive damage exposure as the primary lever in settlement negotiations, because defendants in product liability cases often agree to higher compensatory amounts to avoid punitive damage jury instructions.*
Always Pads Personal Injury Claims: The Mass Tort Track Explained
Always pads personal injury claims operate on a fundamentally different legal architecture than the class action. This distinction matters because most general coverage of this litigation conflates the two tracks.
In a mass tort, each plaintiff retains her own individual claim. Cases may be coordinated for pretrial efficiency in multidistrict litigation, but each plaintiff's damages are adjudicated on individual facts. No plaintiff is bound by another plaintiff's settlement.
This structure benefits claimants with serious health conditions. A woman with Stage III ovarian cancer and a 15-year history of Always pad use has a categorically different claim than a woman who purchased one box of pads and suffered no diagnosed illness.
How personal injury mass tort cases move:
- Individual complaint filed by plaintiff's attorney
- Case transferred to coordinating MDL court if MDL is established
- Plaintiff profile and medical records submitted to common discovery pool
- General causation established through shared expert testimony
- Specific causation established through plaintiff-specific expert testimony
- Individual settlement negotiation or bellwether trial selection
The bellwether trial process is particularly significant. Courts select representative cases for trial. Outcomes in bellwether trials signal to defendants the likely range of jury verdicts, which drives global settlement negotiations.
*Attorney Insight: Attorneys handling these claims note that being selected as a bellwether plaintiff can be advantageous, because defendants often settle those cases on favorable terms rather than risk an adverse jury verdict that signals value to thousands of pending claims.*
Litigation Watch: Personal injury claimants operate on a separate legal track from class action members, with individual damages adjudicated on specific facts, making serious health condition cases worth substantially more than class action participation.
Always Pads Lawsuit Filing Deadline 2026: Statutes of Limitations by State
The always pads lawsuit filing deadline 2026 is not a single date. It is a state-by-state matrix of statutes of limitations that determine when a claim expires.
This is one of the most urgent pieces of information for potential claimants. Missing the deadline extinguishes the right to file, regardless of the merits of the underlying claim.
Statute of limitations framework:
The clock typically starts either at the date of last product use or at the date the plaintiff discovered (or reasonably should have discovered) that her health condition was linked to PFAS exposure. Many states apply the discovery rule, which extends the limitations period for latent harm cases like toxic exposure.
Statutes of limitations by state (selected):
| State | Personal Injury SOL | Consumer Fraud SOL | Discovery Rule Available |
|---|---|---|---|
| California | 2 years | 3 years | Yes |
| New York | 3 years | 3 years | Yes |
| Illinois | 2 years | 5 years | Yes |
| Texas | 2 years | 4 years | Limited |
| Florida | 4 years | 4 years | Yes |
| Pennsylvania | 2 years | 6 years | Yes |
| Ohio | 2 years | 4 years | Yes |
| New Jersey | 2 years | 6 years | Yes |
*Attorney Insight: Attorneys handling these claims consistently advise that waiting for a global settlement announcement before filing creates unnecessary risk, because the global settlement date does not reset individual state limitations periods.*
How to File an Always Pads Lawsuit Claim in 2026
How to file an always pads lawsuit claim in 2026 depends on whether the claimant is pursuing a consumer class action or a personal injury case. The process differs significantly between the two.
For consumer class action participation:
Class members typically do not need to file individual lawsuits. If a class is certified and a settlement is approved, class members receive notice and file a claim form through a court-supervised claims administration process. Deadlines for class claim forms are set by the court and appear in settlement notices.
For personal injury claimants:
Individual plaintiffs must retain an attorney who files a complaint on their behalf. The process generally follows these steps:
- Initial consultation: Attorney reviews medical history, diagnosis records, and product use history
- Case evaluation: Attorney assesses causation strength and damages
- Complaint filing: Individual complaint filed in appropriate federal court
- MDL transfer: Case may be transferred to coordinating MDL court
- Discovery participation: Plaintiff submits medical records and deposition
- Settlement or trial: Case resolves through negotiation or proceeds to trial
Documents claimants should gather now:
- Medical records confirming any PFAS-linked diagnosis
- Receipts, loyalty card records, or subscription records showing Always pad purchases
- Photographs of product packaging
- Prescriptions or treatment records tied to related conditions
*Attorney Insight: Attorneys handling these claims note that loyalty program purchase records from retailers like Target and CVS have been used successfully to establish purchase history in the absence of physical receipts.*
Always Pads Lawsuit Status 2026: What to Expect in the Next 12 Months
The always pads lawsuit status 2026 reflects a litigation approaching its most consequential phase. The decisions made in the next 12 months will determine the litigation's ultimate shape and value.
Several things are expected to happen in 2026:
Class certification ruling: The court's decision on whether to certify the consumer fraud class will define how many plaintiffs can participate in the class track and what total settlement exposure looks like for P&G.
Expert witness rulings (Daubert motions): P&G is expected to challenge plaintiffs' causation experts under the Daubert standard. The court's ruling on which expert testimony is admissible will shape the strength of plaintiffs' case significantly.
Bellwether trial scheduling: If the personal injury MDL reaches the stage of bellwether trials, initial trial dates may be set in 2026, with actual trials in 2027.
Settlement pressure: As litigation costs accumulate and trial dates approach, settlement discussions typically intensify. P&G has significant financial capacity to fund a settlement, but internal pressure to resolve the litigation depends on internal risk assessments of trial outcomes.
2026 projected litigation calendar:
| Anticipated Event | Projected Timing |
|---|---|
| Class certification ruling | Q2 to Q3 2026 |
| Daubert rulings on causation experts | Q3 2026 |
| Bellwether trial selection | Q3 to Q4 2026 |
| Global settlement discussions | Q4 2026 onward |
| First individual trial (if no settlement) | 2027 |
*Attorney Insight: Attorneys handling these claims note that global settlements in PFAS product cases have historically been reached between the Daubert ruling stage and the first bellwether trial, because defendants gain a clearer picture of trial risk once expert admissibility is resolved.*
Litigation Watch: The 2026 calendar includes class certification rulings, Daubert challenges, and potential bellwether trial scheduling, making this year the most legally consequential in the Always pads litigation to date.
Frequently Asked Questions
What is the Always pads lawsuit about in 2026?
The Always pads lawsuit is a federal civil action alleging that Procter & Gamble manufactured and sold feminine pads containing PFAS chemicals without disclosing the presence of those compounds to consumers.
Two separate legal tracks are active: a consumer fraud class action seeking economic damages and a personal injury mass tort for women who developed PFAS-linked health conditions.
The primary court is the Northern District of Illinois, with class certification proceedings ongoing as of 2026.
Which Always pad products are named in the lawsuit?
Multiple Always product variants are named in operative complaints, including Always Infinity, Always Radiant, Always Discreet, and Always Maxi.
Independent laboratory testing cited in those complaints detected PFAS compounds across several product lines, not only one specific variant.
Claimants who used any of these products during the relevant period may have standing to file.
What PFAS chemicals were found in Always pads?
The primary compound cited in the litigation is PTFE (polytetrafluoroethylene), a widely used fluorinated compound that falls under the broader PFAS classification.
Independent testing labs detected PTFE and related fluorinated compounds in the absorbent and outer layers of tested Always products.
Some testing used total organic fluorine analysis, which captures a broader range of fluorinated compounds than compound-specific testing alone.
Who qualifies to file an Always pads lawsuit claim?
For the consumer class action, any person who purchased covered Always products within the applicable state statute of limitations period may qualify.
For personal injury claims, qualification requires documented use of Always pads over a sustained period and a medical diagnosis of a PFAS-linked condition such as ovarian cancer, uterine cancer, kidney disease, endometriosis, or thyroid disorder.
Women with serious diagnoses should consult a personal injury attorney before participating in any class action, as class participation may limit individual recovery.
How much compensation can Always pads claimants receive?
Consumer class action claimants in analogous PFAS product cases have received between $20 and $500 per person in settled class actions.
Personal injury claimants with documented PFAS-linked cancer diagnoses may be in a position to recover between $50,000 and $500,000 or more, depending on diagnosis severity, duration of use, and jurisdiction.
No global settlement has been announced as of this publication, so these figures reflect estimates based on comparable litigations.
What is the filing deadline for the Always pads lawsuit in 2026?
There is no single national deadline. Each state applies its own statute of limitations to personal injury and consumer fraud claims, ranging from 2 to 6 years depending on the claim type and state.
Many states apply the discovery rule, which starts the clock when a plaintiff discovered or reasonably should have discovered the connection between Always pad use and a health condition.
Potential claimants should not assume that waiting for a global settlement announcement preserves their rights, because individual state deadlines run independently of any settlement timeline.
Closing
The Always pads lawsuit is a serious, multi-track federal litigation targeting one of the most widely used consumer health products sold in the United States. The scientific and regulatory picture strengthened considerably after the EPA's 2024 PFAS rulings, and the litigation itself is entering its most consequential phase in 2026.
Any woman who used Always-brand pads and received a diagnosis of cancer, endometriosis, thyroid disease, or a related condition should not wait for a class action notice before consulting an attorney. The personal injury track operates on its own timeline.
An attorney who handles toxic tort or mass tort personal injury cases is the right type of counsel for health-condition claims. A consumer protection attorney is the appropriate resource for economic loss claims. Statute of limitations periods are running now.
